3Wyatt DE,Brooker DS,Connolly JH,et al.Prognostic value of EpsteinBarr virus serology in patients with nasopharyngeal carcinoma.J Infect,1993,26:171-175.
4Sam CK,Abu-Samah AJ,Prasad U.IgA/VCA as a follow-up marker in the monitoring of nasopharyngeal carcinoma.Eur J Surg Oncol,1994,20:561-564.
5ShaoJY,Li YH,Gao HY,et al.Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.Cancer,2004,100:1162-1170.
6Wongkham S,Bhudhisawasdi V,Chau-in S,,et al.Clinical significance of serum total sialic acid in cholangiocarcinoma.Clin Chim Acta,2003,327:139-147.
7Kimura Y,Fujieda S,Takabayashi J,et al.Conventional tumormarkers are p rognstic indicators in patients with head and necksquamous cell carcinoma1.Cancer Lett,2000,155:1632-1681.
8Akcay F,Taysi S,Uslu C,et al.Levels of soluble intercellular adhesion molecule-1 and total sialic acid in serum of patients with laryngeal cancer.Jpn J Clin Oncol,2001,31:584-588.
